Agenus Inc., a scientific-phase biotechnology business, discovers and develops therapies to activate the human body's immune program from cancer and infections in America and internationally. It offers Retrocyte Display, an antibody expression System for your identification of fully human and humanized monoclonal antibodies; and display technologie